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2Abatract
Both in Sdy and in vitro studies have demonstrated that
gossypol has anti-cancer effect. It prolongs life span of Ehrlich
ascites tumour-bearing mice. There is an absence of any sign of
tumour among some mice treated with high dose of gossypol.
Certain biochemical changes were observed accomplished with
gossypol treatment in Ehrlich ascites tumour cell:
1) A decrease in oxygen consumption
2) A decrease in total lactate dehydrogenase activity
3) A decrease in membrane Na+- K+ATPase
4) An increase in membrane protoofytis activity
In addition,in vitro study of drug-treated Ehrlich ascites
tumour cell did not show any significant change in glucose
uptake. However, in the study of rat heatoma, there was a
change in Km and Vmax values at gossypol concentration showing
inhibition of thymidine, uridine and leucine incorporation. Such
kind of change may be due to a reduction of protein synthesis or
a possible interaction between the transporter the drug.
Apart from investigation of the drug effect of gossypol, the
effect of methotrexate is studied. The drug shows differential
killing effect to normal fetal fibroblast and human tumour cells.
Moreover, a similar inhibition of glucose transport is observed
in the human tumour cells by methotrexate.
Besides, membrane properties of the three human head and neck
tumour cell lines (HN-6, HN-6Lr, HN-6n1) were studied. The
metastasis shows the absence of a protein band that exists in the
primary cell 1 ine.In addition, membrane protein patterns of
3tumour cells were significantly different from that of the
primary culture of fetal epithelial cell.
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Nowadays chemotherapy is frequently used in the control
of metastatased tumour cells which may have escaped from
surgery and radiotherapy. In fact, cancer chemotherapy has
played an essential part in cancer treatment because the
efficacies of anti-cancer drugs have improved greatly. This
is due to recent advancement in phar macok i ne t i c studies of
anti-cancer drugs and more understanding in the cytokinetic
of normal malignant cells. Moreover, combination of drugs
in chemotherapy has improved efficacy but reduced toxicity
of anti- cancer drugs.
The importance of drug treatment in cancer therapy has
led to a surge to investigate the action mechanisms of
existing anti-cancer drugs. Meanwhile, potential anti-
cancer drugs have been explored and evaluated. The
effectiveness of the drugs can be tested by either La vitro
or in vivo screen ina systems.
1.1 Drug screening systems
The choice of screening system must be simple, cheap
and the results compatible to the observation in clinical
treatment of cancer patients. There are two common testing
systems: in vivo and in vitro.
l.1.l In vitro systems
Cell culture is usually employed. Cells in the forms of
3monolayer or suspension are treated with drug. The effect
of the drug is determined by direct cell counting, by
incorporation of radiolabelled precursors into
macromlecules (Caiman et al., 1980) or by measuring the
number of clones formed by the drug-treated. cells in soft
agar( Dendy et al. 1983).
In vitro, assays have the merits of simplicity, time
saving and low expense. A direct dose- dependent
relationship can be achieved easily. Another advantage is
that they allow the possibility of studying neoplastic
cells of human origin. This permits investigation of the
efficacy of certain ant i -cancer drug directly on the target
cancer cells (Drewinko, et al. 1980). In addition, cell
cycle specific drug can also be elucidated in vitro.
In vitro systems, however, have a number of defects.
Firstly, the cell culture is in a static environment
different from the dynamic state of animal system.
Secondly, drugs requiring metabolic activation are more
difficult to be studied in the In vitro systems. Finally,
the cytotoxicity of drugs on the hosts' cells are not
considered.
1.1.2 In vivo systems
The use of it vivo system has the advantages of mimicry
of a biological system such as human beings ability in
measure therapeutic index of the host and the cytotoxicity
of the drugs to the normal cells.
The current experimental systems are those of
transplantable tumours that grow rapidly and give
4results within a few weeks of implantation such as L1210
leukemia, P388 leukemla, L5178Y lymphoma, B16 melanoma
Lewis lung tumour and Ehrlich ascites tumour
Encyclopeadia of drugs-in chinese, 1983).
Using animal models as in vivo system, one has to face
several problems. The process of repeated transplantation
may result in a loss of original features of the tumour and
a shortened interm i tot is time. However, the most important
and critical problem is that some agents shown to be active
on L1210 leukemia, a routine in vivo screening system,
failed to kill human neoplastic cells in clinical studies.
(Schepartz et al. 1979).
Recently, the potentials of using nude mice as irk vivo
system for screening anti- cancer drug have been
exploited. Many observations of human tumour transplanted
to nude mice support that the histology and many
biochemical characteristics of the original tumour has been
retained in the heterotransplanted tumour. (Helson et al.
1980
1,2 Tumour models used in this Studie5
1.2.1 Ehlr ich ascites tumour cell
It can be seen that both in vitro and in vivo systems
have their merits and dismerits. Therefore, both in vivo
and jn vitro systems were studied.
Among the in vitro and in vivo systems mentioned above,
Ehrlich asc i tes tumour was chosen because it has long been
used as an animal model for anti-cancer drug studies(
5Yoshida et al. 1971). Moreover, it can be maintained and
studied either Ja v i vo or in vitro culture. Thus, a direct
dose-dependent relationship could be achieved between the
tumour cells and drug concentrations. At the same time, we
could measure the anti-cancer effect and the side effect of
the drug on the animal. I n addition, a number of
biochemical characteristics of Ehrlich ascites tumour cell
have been elucidated. Therefore, we can design experiments
to study any change of these biochemical parameters after
drug treatment. One of the characteristics of Ehrlich
ascites tumour is high rate of aerobic glycolysis, which
is also known to be a common phenomenon of neoplastic cells
( Warburg et al. 1956). The high rate of glycolysis in
Ehrlich ascites tumour is suggested to be a result of
derangement of certain glycolytic enzymes such as hexose
kinase lactate dehydrogenase and an altered Na-- KtATPase
( Lazo et al. 1978 Lazo and Sols, 1980 Scholnick et
al.1973). Since the drug tested in this study, gossypol,
has been found to interfere the' energy metabolism of
spermatozoal cells (Xue et al. 1982), the activities of
lactate dehydrogenase and Na+- K ATPase of Ehrlich ascites
tumour cells were studied after gossypol treatment.
1.2.2 Rat hepatoma, non-transformed human fetal lung fibroblast,
and tumours of human head and neck sguamous carcinomas
In addition to Ehrlich asc i tes tumour, rat hepatoma,
non-transformed human fetal lung fibroblast and tumours of
human head and neck squamous carcinomas were employed as it
6vitro systems. The response of rat hepatoma cells to
gossypol was compared with Ehrlich ascites tumours cells
and also the human cell lines.
As mentioned in the above, drugs which are effective
in animal systems, may not be able to kill neoplastic cells
of human origin. Since it is impossible to do in vivQ assays
in human beings, established cell 1 ines of human tumour
were used as 111 vitro models and their responses to the
drug were compared with that of Ehrlich ascites tumour
cells and rat hepatoma. Human head and neck squamous
carcinomas were chosen because:
1)Squamous carcinomas have accounted for the majority of
human tumours.
2)The squamous carcinoma cell lines include a primary
tongue tumour, a local recurrent tongue tumour and a lymph
node metastastic tumour- all come from the same patient.
Therefore, any difference in drug responses among the cell
lines may imply that tumour cells of different cancerous
stages may have different drug responses to the same drug.
Since drug responses of the same type of tumour also vary
from patient to patient, comparison of drug effectiveness
of different cancerous stages is better to be performed on
tumours that come from the same cancer patient.
Besides, the membrane properties of the tumours of the
same patient can be compared. The change in properties may
also be related to the cancerous stages.•
Drug that is cytotoxic to tumour cells, may also be
harmful to normal proliferating cells such as bone marrow
and other non-proliferating cells. Therefore, the drug
7effect on non-transformed human fetal fibroblast was
studied. Human fetal fibroblast was chosen because:
1) it originates from human tissue.
2) it can grow as i_q vitro culture as tumour cells.
Therefore, the growing conditions of the non-transformed
cells and the tumour cells are the same.
3) human specimen is difficult to obtain and human bone
marrow culture is not available and other cell types such
as human epithelial cells cannot grow as cell culture
under the same growth conditions of tumour cells and fetal
fibroblast.
4) human fetal fibroblast maintained as cell culture
still retains the essential characteristics of normal
cells that it is non-transformed and its-growth is
inhibited at confluency.
Besides in vitro studies of human tumour cell lines,
transplantation of solid tumour in nude mice. However the
animal house does not supply any nude mice and the
maintenance of nude mice is very expensive.
Details of the origin of the tumour cell 1ines were
mentioned in the Appendix I.
1.3 In vitro screening assays used in the studies
Effect of the drug on culture cells was first studied
by counting the number of the cells survived after drug
treatment.This assay usually underestimates the drug
8effect. Therefore it is only a preliminary estimation of the
drug effect. A more sensitive assay was to observe the
inhibition of DNA, RNA and protein synthesis in the cells
after drug treatment and these inhibitory effects were
reflected from the amount of 3 H- labelled thym id ine,
uridine and leucine incorporated into the cells.
Incorporation assay may indicate the site of drug action
at the level of DNA, RNA or protein synthesis. In fact most
of the known anti-cancer drugs inhibit the growth of tumour
cells by disturbing the DNA, RNA and protein synthesis of
the cells. Fig. 1.1 showed the site of action of common
anti-cancer drug( Weber et al. 1977).
Delayed drug effect may also be seen in certain anti-
cancer drugs especially the drugs which affect cells at the
S phase o f the cell cycle. The pol i ferat ion of the cells
may be terminated after drug treatment but the cells
remained viable for a period of time. This delayed effect
can be studied by clonogenic assay. In our studies, we did
not use clonogenic assay because the cell lines required a
more complicated growing condition when grew in soft agar.
In addition, the time required for the formation of clone
was 14 to 20 days. Therefore it was very time consuming. In
order to study the delayed effect of the drug, the cells
after drug treatment were allowed to grow in fresh culture
medium and recovered for 48 hours. Af ter the period of
recovery, the dead cells would detach from the growth
surface leaving behind the viable cells. Therefore, the
amount of cell surviving can be determined by cell counting
or by measuring the total protein content of the cells on
Figure 1.1 The site of action of common anti-cancer drugs
The thick arrows indicate increased rn:,ir actcitie
in neoplasi. The dotted arrow indicate decease
ecie activities in tuiour cells. In the diaqrai
key enzyies are targets of aoti- cancer drugs.
APA- C: arabinosyl cytosine
ATP: adenosine triphosphate
9udP: bro«od«oxyuridine
CHP, CD?, CTP: ctidine lonephosphate, diphosphate
triphosphate
ijTP: guar.osine triphosphate
0P: orotidine- 5'- phosphate
PALA: N- (phosphonacetyP- L- aspartate
PRPP: phosphorlbosyl pyrophosphate
TDPf TKP, TTP: thymidine diphosphate, tonoohosphat
Ifipnuopnalr
UDP, UMP, UTP: uridine diphosphate,, »onophosphate
triphosphate
Weber, G. (1977) Enzymology of Cancer Cells(Part I) The New
England Journal of Medicine Vol. 296 No. 9 486-492
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the growth. surface. Since the area of the growth surface is
0.5 cm2 protein determination by the method of Lowry
(1951) would be more accurate than direct cell counting.
1.4 jiochemlcal studies ,after drug treatment
A number of biochemical changes may occur after druc
treatment. DNA, RNA and protein synthesis may be inhibited.
The energy metabolism of the cells may also be altered.
The incorporation assay of labelled thymidine, uridine and
leucine is not only a useful screen assay of the drug and
it also reflects the synthesis of DNA, RNA and protein
in the presence of drug. The disturbance of energy
metabolism can also be reflected from the rate of
oxygen consumption and the activity of lactate
dehydrogenase (details has been mentioned in section
1.2.1). In addition,it has been reported that the viral
transformed cells have a higher glucose uptake rate than
the normal counterparts (Weber et al. 1984). However, other
workers could not show such kind of change when the
primary culture of tracheal epithelial cells was
transformed by chemical carcinogen (Wasilenko and Marchok.,
1984). Though the relationship between an altered glucose
transport and the state of transformation remains unclear,
it was found that the glucose transport of Ehrlich ascites
tumour was. affected after methotrexate treatment.( Chan et
al.1983; Kaminska et al. 1979) This effect of
methotrexate on the other cell lines remains unknown.
Therefore the effects of the drug on the human cell lines
were also studied. Since gossypol has been implied to
interfere with the energy metabolism of the drug-treated
cell (Floridi et al. 1981), it will be possible that the
drug may also cause an alteration of glucose transport.
Thus the glucose uptake of tumour cells was measured after
It was found that glucose uptake in various tumours ai
normal cell lines including Ehrlich ascites tumour cells
f
mediated by a saturable facilitated diffusion and by
unsaturable diffusion. The saturable diffusion involves
carrier mediated transport while the unsaturable one is di
to passive diffusion across the plasma membrane. (Chan e
al.1983; Plagemann and Bernlohr 1972; Plagemann ar
Richey 1974) H-2- deoxy-D-glucose, an analog of C
glucose, was employed in glucose uptake as it is nor
metabolized by the cell and it shared the same carrier c
D-glucose. (Klip et al 1982)
The amount of glucose carrier was estimated by the amoun
of D-glucose sensitive cytochalasin B binding site
Cytochalasin B is a mold metabolite and has been shown t
to be a potent, reversible inhibitor of sugar uptake in
cultured cells (Kletzien, et al. 1972), red blood cells
Hela cells (Lin et al. 1974) and Ehrlich ascites tumou
cell (Cuppoletti et al. 1981 ).The compound has three type
of binding sites on Ehrlich ascites tumour. Only th
-i





2. In vivo studies of the effect of a s s y p o l on Ehrlich A t s
Tumour (EAT) Ce1is
2.1 Introduction
Gossypol is a yellowish polyphenol is pigment first
isolated at the end of the 19th century from the cotton
plant (Gossypium sp.). Structure of gossypol is shown in
fig. 2.1.During the 1970s, gossypol was found by Chinese
scientists to be active as an oral male anti-fertility
agent. Its action mechanism is still under investigation,
but it does have a direct effect on sperm. Gossypol
exhibits a broad spectrum of activity on cellular processes
1) it inactivates LDH X, an isoenzyme of LDH found in sperm
( Maugh T.H, II, 1981).
2) it uncouples electron transport and oxidative
phosphorylation( Abou- Donia Dieckert, 1974 Killion
et al., 1968).
3) reduces ATP content of spermatozoa( Tso et al., 1982).
4) Gossypol does not seem to be a mutagen as shown by the
Ames Salmonella test( Wang et al., 1980 Colman et al.,
1979).
5) its acetic acid derivative inhibits two forms of ATPase:
M9 2+ -dependent and Mg 2+ Cat -dependent A TPa s e as well
as Cat uptake by plasma membranes from ram and bull
)spermatozoa.( Bre i tbart et al. 1984
6) it inhibits the activity of the enzyme acrosin and
arrests spermatozoal motility( Tso and Lee, 1981).





CH3 CH3 CH3 CH3
Fig. 2.1 Gossypol
Recently, the possibility of employing gossypol as
an anti- tumour agent has attracted attention of a number of
laboratories (Tso, 1984; Tuszynski Cossu, 1984; Floridi et
al., 1983, Floridi et al., 1984). Tso( 1984) has
demonstrated that gossypol injected peritoneally can increase
the survival of EAT-bearing mice. Ln vit.rn studies
indicated that melanoma and colon carcinoma cells which were
more sensitive to the drug, contained more cationic forms of
LDHase. This implied that the drug might affect lactate
production of sensitive cell lines (Tuszynski Cossu, 1984).
2. 2 Aim of study
The aim of the present study is to investigate further
the effect of gossypol on Ehrlich ascites tumour cells. The
potential of gossypol as an anti- cancer drug is tested by
measuring the survival rate of tumour- bearing mice after
drug treatment. In addition, the tumour burden of mice was
also measured. Since it has been reported that gossypol
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Inhibits respiration and lactic dehydrogenase X in human
sperMatozoal cells( Chen Li et al. 1978), the effects
of gossypol on energy metabolism of the tumour cell were
assayed by determining any changes of oxygen consumption
rate and the total activity of lactic dehydrogenase. The
possible change in membrane properties was examined by
measuring the activity of Na+/ K ATPase. In addition,
proteol yt is activity of the drug- treated tumour cell was
also assayed.
2.3 Materials and Methods
Ehrlich asc i tes tumour cells were propagated in 30-35 g
male ICR mice which were harvested and transplanted to new
hosts every 7 days.
Gossypol, in the form of gossypol-acetic acid was
purchased from Sigma Chemical Co (U.S.A.). All other
chemical reagents used in the experiments were of
analytical grade.
2.3.1 Survival studies
Seventy- five mice of similar body weight were
inoculated intraperitoneally with 0.2 ml of freshl}
7
harvested ascitic fluid( 2 x 10 cells). On the same da)
of inoculation of the tumour cell, gossypol wac-
administered orally by an animal feeding tube (Popper S
sons, inc.U.S.A) to four groups of-nice( 12 mice per
group). The amounts of gossypol received by each animal ir
different groups were 25, 50, 100 and 200 pg per -0.1 *1
gossypol solution respectively. The control group receives
16
0.1 Ml solution of normal saline. The body weight and
survival were monitored everyday for 16 days.
In another study, gossypol was applied by a single
intraper itoneal injection of 0.1 ml of various
concentrations of gossypol solution per mouse.
The mice 'killed by cervical dislocation on 7th
day were dissected and tumour cells were collected by
exhaustive drainage. Pooled tumour cells were washed once
with PBS and twice with half-isotonic saline to lyse the
blood cells. Cell number in the ascitic fluid was recorded
by hae mocytome ter counting and the viability was
determined by trypan blue exclusion assay.
2.3.2 OxygeII consumption rate
The rates of cellular respiration were measured by a
Clark oxygen electrode (Yellow Springs Instruments model
5350), which was equipped with an ultrathin Teflon
membrane. The method was a modified one of Fl or id i (1983).
0.2ml of cell suspension( 6 x 107 cell) was added to 2.8
ml of buffered medium (M199) and the reaction rates were
determined by inserting the electrode into a thermostated
(37°C) closed glass chamber of 3-ml capacity. Allowed the
specimen to reach a steady state. The respiratory rate was
recorded for five minutes-
2.3.3 Lactate dehydragen ase activity
Ehrlich Ascites tumour cells washed as described above
were lysed by son icat i on for 30 seconds (3 times), in the
sonicating medium( 50 mM triethanolamine, 1mM EDTA, 2 mM
17
HgC12, 30 mH 2-mercaptoethanol, pH 7.6). Supernatant
was obtained after centrifugation at 10000 X g for 10 min.
The enzyme activity was assayed in the medium of 0.1 H
triethanolamine, 0.12 mM NADH, 1 mM pyruvate- and 2.5 uH
rotenone, pH 7. 2. The enzyme activities were measured as
the absorbance change at 340 nm by the Cary 210
Spectrophotometer. The initial linear change of absorbance
was used for the calculation of initial reaction rate of
nzyme activity assayed at 25 OC.( Brooks, 1976)
2.3.4 Plasma m mbrane prepares tinnration
Crude plasma membrane were prepared by a method
modified from Kamat and Wallach (1965). Briefly, tumour cell!
were first washed in PBS and blood cells removed by washing
with half isotonic saline. Cells were lysed by sonication
Sonicator Cell Disruptor, model Wzoor, Heat Systems-
Ultrasonics Inc.) for 3 min while suspended in 5 mM Tris
and 0.2 mM MgSO4 (pH 7.4). Nuclei, mitochondria and
lysosomes were sedimented by centrifugation for 15 m in at
1000 X g. Microsomes were sedimented by centrifugation for
45 min. at 16000 X g. After two washes, portions of 4 ml of
sample suspension were carefully layered on 26 ml linear
Ficoll gradients( 5- 25% in 0.25 M sucrose). The
centrifugation was performed using a SW 25.1 Beckman
rotor at 24000 rpm for 30 min. The top layer( about 8 ml)
contained the enriched membrane fraction as judged by
subsequent enzyme markers studies.
2-3.5 Na K- ATPase assay
(Na+ K)- stimulated, Mg- dependent adenosine
triphosphatase is a marker for plasma membrane. Its change
Is Indicative of the state of the active transport of
sodium and potassium which is an essential cellular process
which maintains a 'healthy' state of the cells.
The assay system is modified from Post and Sen
(1967), The reaction mixture for determining total ATPase
contained:
30 mM imidazole, 30 mM glycy1glycinej
5 mM MgClo', 0.5 mM EDTA,
100 mM NaCl and 20 mM KC1, pH 7.4
The amount of total ATPase activity inhibited by 0.4
mM ouabain was attributed to Na+- ATPase.
20- 50 jug crude membrane preparations were added to
the appropriate buffer to a final volume of 500 ju 1. After
pre-incubation for 5 min, the reactions were started by
adding 200 ul of 100 mM ATP and the incubation allowed to
proceed for 30 min at 37 °C. The reaction was stopped by
adding 0.5 ml of ferrous su1phate-ammoniurn molybdate and
the amount of Pi released was measured by absorbance at 660
2.3.6 Assay of proteolytic activity
The proteolytic activity of membrane was assayed at
pH 7.5 (0.1 M phosphate buffer) using the hide-bound azo-
dye Azocoll and Azocasein as the substrates according
to Bosmann( 1969). Azocoll, 25 mg was mixed with 100 jug oi
membrane protein. The reaction mixture was incubated in a
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shaking water bath at 37 0 C for 3 h. The reaction was stopped
by rapid cooling to 00C and substrate Azocoll centrifuged
down and absorbance measured at 520 nm.
2.4 Results and discussioi
2.4.1 Survival studies
a. Oral administration of gossypol to ascites tumour cells
Oral administration of 25- 200 pg of gossypol to
tumour- bearing mice did not show any significant effect
in prolonging the l i fe of mice, fig. 2- 2.
The proliferation of the tumour was measured by
the amount of increase in body weight of tumour- bearing
mice as compared with their body weight before tumour
transplant. The degree of proliferation of tumour cells
was much smaller in the mice receiving 100 to 200 fag of
gossypol per day but the animal could not survive
longer, fig. 2- 3. It could be due to the toxic effect
of gossypol to the animal especially the gastro-
intestinal tract. Autopsy of the mice revealed that
gossypol accumulated in the stomach.
b. Intraperitoneal administration of anssypnl
It was observed that mice could tolerate better if
gossypol was given peritoneally. Intraperitoneal
administration of gossypol was used. This test aimed to
verify and extend the previous results( Tso, 1984).
Seventy two mice were divided into 2 schemes( 9 mice per
jug G o ss y poI mous ed ay
Fig. 2.2 The effect of oral administration of gossypol t
Fhr 1 ich Ascites Tumour bearing- mice.
Days after inoculation
Fig. 2.3 The effect of oral administration of gossypol to
Ehrlich Ascites Tumour bearing- mice. Weight of mice
at the day of inoculation was expressed as 100 %
The increase in body weight of tumour bearing mice was
compared to that at the zeroth day of inoculation. The
increase in body weight was assumed to be directly
proportional to the tumour size. Mean values of body
weight were expressed.
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dose). In scheme(I) mice were given gossypol i. p. four
days after tumour transplant( 2 X 10 7 cells/ mouse). In
scheme (II), gossypol was given I.p. one day following
tumour cells transplant. Gossypol administration was
stopped on the 12th day of tumour cells transplant.
Result of scheme I was shown in fig. 2- 4
Although initially( up to day 13th), the percentage of
death was much higher in the control group than the 100 ug
and 200 ug treatment group, the 200 ug gossypol treatment
group also showed a high death rate. On day 17, all 4
groups had comparable death rate.
In scheme II fig. 2- 5 whereby mice were given
gossypol sooner, the results were more encouraging. On day
15th the percentage of death of the control group was
almost double of the gossypol treatment groups. The
gossypol- treated mice was better than the control. No
distention of the abdominal cavity was observed in drug-
treated mice which suggested that tumour proliferation was
arrested.
2.4.2 Tumour size
Fig. 2- 6 shows that daily administration of gossypc
could suppress the growth of Ehrlich ascites tumour cells.
The results showed markedly that the effect was dose
dependent. The action of gossypol was most dramatic over
100 1ug gossypol/ mouse/ day. At 200 )ug gossypol per day,
only 1/4 of the group had any observable sign of tumour.- At
300 ug gossypol per day, one mouse out of nine had the s ign
of tumour. However, the viability of the tumour cells
Days after E.A.T. transplant














Days after E.A.T. transplant
Fig. 2.5 Effect of intraperitoneal adminstration of gossypo
(scheme II)
Fig. 2.6 Tumour sizes of E.A.T. bearing mice after 25- 200 ug
gossypol treatment intraperitoneal were determined on
7th day. The tumour sizes were measured by exhaustive
drainage of E.A.T. cell and then counted by
haemocytometer. Average values of 6 replicates were
e xpressed.
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harvested remained unchanged in all groups as determined by
trypan blue exclusion assay. The physical state of mice
treated by these high doses of gossypol appeared normal and
healthier than the control tumour bearing mice. It should
be noted that single-dose oral LD50 of gossypol for mouse
is 500- 950 mg/ kg( Qian and Wang, 1984). The highest
dose in our regimen was about 7.5 mg/kg/day which is within
the tolerant level for mice.
2.4.3 Oxygen consumption, rates
Oxygen utilization rate by Ehrlich ascites tumour
cells was measured by a Clark oxygen electrode. Tumour
cells taken from gossypol treated mice showed a reduction
of 20% to 30% in oxygen uptake rates as compared to the
control tumour cells, fig. 2- 7. Similar inhibition of 02
consumption has also been reported in isolated mitochondria
of rat testis at high dose of gossypol and the drug is
reported to inhibit the respiratory chain of mitochondria.
ne et al. 1982).
2.4.4 Effect of gossypol on the lactate dehydrogenase activities of
Ehrlich ascites tumour cells.
Lactate. dehydrogenase (LDH) is the terminal
enzyme in anaerobic gl ycol ys is. The enzyme catalyzing the
reversible reduction of pyruvate to lactate, has been shown
to exist in five genetically distinct molecular forms
in mammals (isoenzymes). The X-isozyme of lactate
dehydrogenase ( LDH- X) which was found to be present in
snPrmAtozoa was particularly sensitive to gossypol (Olyiati
Fig .2.7 The oxygen consumption rates of
Ehrlich ascites tumour cells
after 25-300 ug gossypol treatment
. 2 10 cell/ml was used to measure
the rate of oxygen consumption.
Fig . 2.8 The activity of lactate
dehydrogenase of Ehrlich
ascites tumour cell after




Fig. 2- 8 shows the effect of gossypol on total
LDH activity of tumour cells taken from gossypol treated
mice. The activity of LDH was expressed as O,D. 340
change/ min/ 4 X 104 cells. It can be seen that total LDH
activity of the cells decreased in a dose dependent manner
after gossypol treatment. At 50 iig gossypol/ day or higher
dosage, the LDH activity decreased by 30%. It can be
implied that is yiyo gossypol treatment did affect lactate
production by a reduction of the enzyme activity. Previous
report has shown that there was a reduction of LDH- X and
LDH 1 level in human sperm after gossypol treatment (Xue
et al. 1982). In addition, LDH- X activity was not
observed in the tumour cell.
2.4.5 Membrane proteolyt is enzyme activity
Effect of gossypol on the proteol yt is activity of
Ehrlich ascites tumour cell membrane was studied by
measuring the enzyme activity of the purified membrane at
neutral pH. The activity was quite weak and thus 3 hours
incubation time was needed to obtain measurable release of
azo-dye. Addition of 0.2 a Triton X- 100 helped to
solubilize the membrane vesicles and made the membrane
bound enzymes accessible for reaction. Enzyme activity was
expressed as unit defined by Moore et al. (1970). Results
were shown in Table 2- 1 in which activity of gossypol
treated group was compared to the control. The mean value
of the four groups showed a 2- fold increase in the enzyme
activity as compared to the control. It is postulated that
increase in membrane proteolytic activity is an indication
of increase of turnover of membrane proteins and
glycoproteins. If it is not compensated by an increase in
the biosynthesis, this will lead to a net decrease in the
number of membrane functional proteins.
Table 2- 1
The membrane proteolytic activity of Ehrlich ascites
tumour ce11.
GossVDol concentrat i on proiteo1vtic act 1vitv











Proteolytic activity is expressed as the ratio of the
activity of drug-treated cell to that of the control. The
proteolytic activity of the control is assigned to 1
Experimental details using Azocaesin as substrate are
described in the text. Values are the mean of 3 separate
measurements.
2.4.6 Na K~- ATPase activity of purified o1 asma_membrane o±
Ehrlich ascites tumour cells
Of the six groups of Ehrlich ascites tumour cells,
the membrane preparations were obtained under identical
conditions and could be presumed to achieve similar degree
of purity. Na+ K- ATPase activity reflects the
metabolic state of the cell as a whole. Hence, it was
determined in this study. From the preliminary- results
obtained, it seemed that gossypol treatment of 100 ugday
or below did not affect the enzyme activity, but dosage
above 100 pg day decreased the Na+ K+- ATPase activity
drastically, Fig. 2- 9.
This could be due to either a direct effect of
gossypol on the enzyme or by increasing the proton
permeability across the plasma membrane-( Reyes et al.
1984); or indirectly on the DNA and protein metabolism of
the cells. It would be of interest if the effect of
gossypol on the ATPase of non-transformed cells were also
studied.
2.5 Conn!usiop
Several conclusions can be drawn from this series of
experiments:
1) Gossypol suppressed the growth of Ehrlich ascites tumour
cells in vivo in a dose-dependent relationship. At the
same time the number of survival days of the animal was
lengthened.
2) A slight decrease of oxygen consumption rate and a similar
decrease of LDH activity was found after gossypol-
treatment i n vivo. This suggests that gossypol may affect
the energy metabolism of the tumour cells.



















ig gossypol mouse day
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Fig. 2.9 The activity of Na ATPase activities
after 100-300 ;jg gossypol treatment.
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3. In vitro studies of the effects of oss of on different
cell lines
3.1 introduction
In y-ly studies of Ehrlich ascites tumour-bearing mice
have shown that gossypol could prolong the life span of the
nice. However, th yiy studies were usually complicated by
other biochemical and physiological factors such as drug
metabolism, rate of drug absorption and clearance etc.
Therefore, in yltro cell culture system which is relatlvely
free from the interference of the above factors, may be a
better approach for studying the direct effects of drugs on
tumour cells.
The purpose of this study was to determine the effects
of gossypol irk vitro. Three aspects of the drugs were
studied:
1) effects of drug on DNA, RNA and protein synthesis.
2) the abilities of cells to recover after drug treatment.
3) effects of the drug on glucose transport of cultured
cells.
The cytotoxicity of gossypol in Ehrlich ascites tumour
was compared with other cell lines: one rat'hepatoma (H-
35), one human fetal lung fibroblast cell line and three
human head and neck cancer cell lines originated from
different sites of the same cancer patient: HN-6 (primary
tongue cancer), HN-6Lr (local recurrent tongue cancer),
and HN-6n1 (submandibular lymph node metastasis). Besides,
the glucose transport of rat hepatoma was also investigated
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and compared with Ehrlich ascites tumour cell.
3. 2 Materials and methods
3.2.1 Cell culture
3. 2. 1a Preparation of medium
Culture medium was prepared by dissolving the powder-
fora medium( by Gibco) with double distilled water.
Dulbecco's Modified Eagle's medium (DMEM) was
supplemented with 3.7 g/ 1 NaHCO3 and 35 g/ 1 D-glucose
while Earle's Minimum Essential medium (MEM) was
supplemented with 2. 2 g/ 1 NaHCO3, 292 mg/ 1 L-gl utam ine
and 2 g/ 1 D-glucose. The medium was sterilized by
millipore filtration C pore size: 0.22 ui) and stored at
40 C. Sterility test was performed by inoculating an
aliquot of filtered medium at 37 0C for two weeks. Just
before use, the medium was supplemented with fetal calf
serum and antibiotics.
3-2.1b gutine pas sage of cell lines
All manipulations for cell culture were performed under
a laminar flow hood (Baker) using sterilized apparatus and
glasswares.
Human head and neck tumour cell lines, human fetal lung
fibroblast and Ehrlich ascites tumour were cultured in DMEM
supplemented with 10% fetal calf serum and antibiotics (1
dug/ml streptomycin, 1 unit /ml penicillin G and 1 pg/ml
minocycline). 2.5 pg/mi fungisone was added occasionally.
Rat hepatoma (H-35) were maintained in HEM supplemented
with 5 fetal calf serum and the same concentration of
antibiotics. r.
All the cell lines except Ehrlich ascites tumour cell
were routinely maintained in 25 cm2 culture flask
(Sterilin). with 4-5 ml culture medium at 37 °C, in an
atmosphere of 5 C02 in air.
Near confluency, the cell lines were first rinsed with
basic balanced salt solution plus EDTA (0.2 g Na Versenate,
8 g NaCl, 0.2 g glucose, 0.01 g phenol red in one litre of
distilled water, pH 7.2- 7.4). Then the cells were
detached from the culture surface by incubation with 0.005
% trypsin (Sigma, type III) in balanced salt solution.
Trypsinization was stopped by the addition of culture
medium supplemented with fetal calf serum. The trypsin
solution was removed by centrifugation at 500 x g for 5
minutes and the supernatant was aspirated. The cell pellet
was then resuspended in culture medium. One quarter of cell
2
suspension was dispensed into 25 cm culture flask
containing 4 ml culture medium. The flask was then kept at
37 °C, in an atmosphere of 5% C02 in air.
Ehrlich ascites tumour cells were cultured for 24 hours
in a number of experiments. The cells were first obtained
from the ascites fluid of Ehrlich ascites tumour-bearing
mice and then washed with sterile half-saline solution
followed by two washes in sterile phosphate buffered
saline.The cells were then resuspended in DMEM supplemented
with 10% fetal calf serum, antibiotics and Hepes (20 mM).
The cells were placed in culture flask at a concentration
0
of 1 x 10 cell ml.
3.2.1c Storage of cell by freezing
The cultures were maintained at log phase of growth by
routine subculture of cells. For storage, the cells were
trypsinized from the growth surface and then resuspended in
M199 medium containing 20 fetal calf serum and 10
dimethyl sulphoxide. Cell concentration was around 5 x 10
cells ml. One ml of cell suspension was then placed into
a plastic ampule and sealed. The ampule was placed 8 cm
above the level of liquid nitrogen and cooled for 3 hours.
Afterwards, the ampule was stored in liquid nitrogen.
3 3 3
3.2.2 Pulse labelling of H-thvmidine, H-uridine and H-leucine
The method was modified from Wilson C1984). The
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cells grow as monolayer were first placed at 1- 2 x 10
4
cell well 0.2 ml( 5 x 10 cell well for hepatoma)
into 96- well micro-titration plates (Sterilin) and
incubated for 16- 24 hours. The growth medium was then
fsu
replaced by culture medium containing the drugs and further
incubated for 24 hours. At 22 hours, 5 1 of medium
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containing 3H- uridine, methyl- H- thymidine and L- 4,
5-3H- leucine(Amersham) was added to each well separately.
The final radioactivity per well was 0.25 ,uCi. After
incubation, cells were immediately washed two times with
ice-cold phosphate buffered saline (PBS) and then three
times with 1.5% perchloric acid followed by absolute
ethanol. The acid insoluble residue was hydrolysed in 5 H
O 3
perchloric acid at 80 C for 1 hour in H-uridine and H-
thymidine incorporation assays and the residue was
solubilized in 0. 1 N NaOH in H-leucine incorporation assay.
The residues were then mixed with toluene- triton X-100
scintillation fluid and the radioactivity was determined by
a Beck man LS- 7 000 liquid scintillation counte r.
For suspension culture, the procedure was modified.
Ehrlich ascites tumour cells were plated at 2 x 105 cell
well in 96 well culture plate with different concentrations
of drug and incubated for 24 hours at 37 °C. At 22 hours, 5
pi of medium containing radio-1abe11ed nucleosides was
added to each well. The final radioactivity per well was
also 0.25 uCi. After incubation with radioisotopes at 37°C
for 2 hours, the cells were then harvested with saline
through GF C filter by cell harvester. The filter was
subsequently washed with 5% trichloroacetic acid and
absolute methanol. Filter paper were dried in air and
placed in scintillation vials containing 5 ml toluene-
scintillant. The radioactivity was measured with a Beckman
LS-7000 liquid scintillation counter.
3.2.3 Cell recovery assay
The assay was modified from Wilson (1984). Cells were
first plated at 2 x 104 cell well into 96 well flat
bottom micro-1itrat i on plate (Sterilin) and incubated at 37
°C for 18 hours. The growth medium was then replaced by
culture medium containing drugs at different concentrations
and incubated for 24 hours at 37 °C in an atmosphere of 95
air 5 H C02• The cells were then washed twice with
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phosphate buffered saline and allowed to grow in fresh
medium for 48 hours. After the further incubation period,
the cells were again washed twice with phosphate buffered
saline before solubilized In 0.1 N NaOH for protein
determination by the method of Folin-Lowry. (Lowry, 1951).
3.2.4 deoxy-D-glucose uptake
2-deoxy-D-glucose uptake in suspension was applied to
Ehrlich asc i tes tumour and hepatoma cells. The assay method
was performed according to Chan (1983) with minor
modification.
Ehrlich ascites tumour cells at the concentration of 1
x 10 7 cell/ ml were equilibrated to 37 °C and 0.1 ml cell
suspension was mixed with 0.1 ml pre-warmed 2-deoxy-D-
3H-glucose (luCi/u mole)- to give a final concentration of
0.06.25- 2 mM and incubated for 30 s. On the other hand,
hepatoma cells at the same cell concentration was mixed
with the same specific activity of 2-deoxy-D-3H-glucose to
give a final 2-deoxy-D-glucose concentration of 0.125- 1
mM and incubated for five minutes. The uptake process was
terminated by addition of one ml ice-cold phosphate
buffered saline supplemented with 40 mM 2-deoxy-D-glucose.
Cells were collected by centrifugation at 10000 X g for 30
seconds in an Eppendorf 5414 model microcentrifuge. The
supernatant was removed and the cells washed once with I ml
of the same buffer. Cell l ys i s was accomplished by the
addition of 0.1 ml triton X-100. 1 ml of triton X-toluene
n ascintillant was added and the radioactivity counted in a
Beckman LS-7000 liquid scintillation counter. Non-specific
uptake was corrected by subtracting the uptake in the
presence of 10 cytochalasin B. The respectively Km and
Vmax values were determined by double reciprocal plots.
a modified Kreb-Ringer bicarbonate buffer was replaced for
the PBS in glucose uptake of hepatoma (the buffer included
5 (wv) of BSA).
3.2.5 Equilibrium binding of cvtochalasin B
Equilibrium binding of cytochalasin B was performed
according to Chan (1983) with minor modification. Around 5
0
x 10 cells in 1 ml phosphate buffered saline were
3- 7
incubated with 0.02 ,uCi( H)-cytochalas in B and 2 X 10 to
-6
2 X 10 M cytochalasin B for 30 minutes at room temperature
After incubation, the supernatant was separated from the
pellets by centrifugation at 10000 X g for 20 minutes. The
radioactivities in the supernatant and pellet were
determined and the percentage of cytochalasin B bound to the
cells was then calculated. To assess the glucose
reversible binding of cytochalasin B, total binding in the
absence and the presence of 500 mM D-glucose were measured
and the difference obtained. Maximal glucose-sensitive
binding (Band the apparent dissociation constant (Kd) were
determined by Scatchard analysis (1949).
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3,3 u1ts and discussion
3.3.1 Cytotoxic effect of gossypol on different cell lines
Cytotox.icity of the drug was determined by three
criteria: the number of surviving cells after drug
treatment, the inhibition of incorporation of 3H-precursors
of DNA, RNA protein synthesis, and the extent of
recovery of cells after gossypol treatment. Six cell lines
have been studied. They included: Ehrlich ascites tumour,
rat hepatoma (H-35) and four human cell lines (one fetal
lung fibroblast and three head neck squamous carcinoma
cell lines). Among these cell lines, Ehrlich ascites tumour
cells have already been found to be sensitive to gossypol
from in viva studies.
3.3.2 Effects of aossypol on growth and viability of tumour cell
Fig. 3-1 showed the cell number and the viability of
Ehrlich ascites tumour cell after 24 hours gossypol
treatment.It would appear that the drug did not affect the
growth and viability of Ehrlich ascites tumour cells
significantly at low concentration C up to 20 aM). At 30
PM of gossypol, the inhibitory effect on growth of the
tumour cells become more prominent and the viability of the
cells declined to about 55%
Fig. 3-2 showed the number of surviving hepatoma cells
(H-35) after 24 hours gossypol treatment. There was a dose
-dependent relationship between the number of surviving





























Fig. 3-1 The percentage of cell number and cell viability




























1 0 20 30 4C
gossypol conc. (uM)
Fig. 3-2 The number of hepatoma cell adherent after 24 hours
gossypol treatment. The dead cells were detached
and washed away while the remaining cells were counted
with a haemocytometer.
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was reduced to half at around 18 uM of gossypol
concentration. However, the concentration of gossypol
required to reduce the same amount of Ehrlich ascites
tumour cell was above 33 1uM gossypol concentration. This
demonstrated that gossypol was more effective on rat
hepatoma than on Ehrlich ascites tumour cell under our
assay conditions.
3.3.3 Thymidine, uridine and leucine incorporation in culture
gel 1 lines after aossypol treatment
Cell counting and cell viability measurement of drug-
treated cell lines was only a preliminary study of the drug
effect. A more sensitive drug assay was performed. This was
the pulse labelling of 3H-thymidine, 3H-uridine and 3H-
leucine of cell lines after treatment with different doses
of gossypol. 96 well multi-titer plate was employed in the
assay. The degree of incorporation of labels was expressed
as the c.p.m. per well. The total protein content of cells
per well was also determined. Fig.3-3 to fig. 3-8 showed
the effects of gossypol on inhibition of incorporation of
thymidine, uridine and leucine in the six cell lines.
Among the cell lines tested, gossypol appears to affect the
incorporation of thymidine, uridine, and leucine to a
similar extent. When the results of radioisotope
incorporation tests were compared with direct cell
counting, the former demonstrated a more sensitive
response to gossypol at low concentrations. In the example
of Ehrlich ascites tumour cell, the cell counting assay
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Fig. 3-3 The percentage of thymidine, uridine
incorporation of Ehrl ich ascites tumour cell after
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Fig. 3-4 The percentage of thymidine, uridine and leucine
incorporation of hepatoma (H-35) after 24 hours
gossypol treatment. The cell survived after
gossypol treatment was expressed as the percentag
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Fig. 3-5 The percentage of thymidine, uridine and leucine
incorporation of fetal lung fibroblast after 24 hours
gossypol treatment. The cell survived after gossypol
treatment was expressed as the percentage of protein
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Fig. 3-6 The percentage of thymidine, uridine and leucine
incorporation of HN-6 after 24 hours gossypol
treatment. The cell survived after gossypol
treatment was expressed as the percentage of
protein content of the control.
ice 11 survived
tihym i d i ne
uridine
leucine





























10 20 30 40
gossypol conc. (juM)
Fig. 3-7 The percentage of thymidine, uridine and leucine
incorporation of HN-6Lr after 24 hours gossypol
treatment. The cell survived after gossypol treatm

































Fig. 3-8 The percentage of thymidine, uridine and leucine
incorporation of HN-6nl after 24 hours gossypol
treatment. The cell survived after 24 hours
gossypol was expressed as the percentage of





The values are presented as mean+ S.E.M. for
triplicate results
gossypol conc (uM)
pM. However, the incorporation assay showed a similar
degree of drug response at around 25 pM gossypol
concentration. In rat hepatoma (H-35) cell, the cell count
assay showed a 50% decrease of cell number at 20 ph
gossypol concentration but the incorporation assay-showed a
similar inhibitory effect at around 10 pM. This higher
sensitivity of isotope incorporation studies was also seen
in the human head and neck tumour cell lines. At around 1C
pM gossypol concentration, the incorporation of
radio1abe11ed precursors into the head and neck cell lines
was decreased to 50%. This decrease of incorporation of
thymidine, uridine and leucine among the cell lines was
partially due to a decrease in cell number in the culture
well which was reflected by a drastic decrease in total
protein content per well. The non-neop1 astic cell culture,
fetal lung fibroblast also demonstrated a decrease in
thymidine, uridine and leucine incorporation after gossypol
treatment but the total cellular protein per well at the
end of drug treatment was not significantly affected
throughout the whole range of gossypol concentrations. A
relatively high dose of gossypol, 15 pM, was also required
to reduce the percentage of incorporation to 50% in
fibroblast cells. This showed that the human fetal
fibroblasts were relatively resistant to the action of
gossypol than the head neck cell 1ines and the rat
hepatoma cells under our experiment conditions.
Incorporation assay reflected that both non-neop1 ast ic
and tumour cell 1 ines were affected by gossypol. Making a
comparison among the cell lines showed that hepatoma was
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the most sensitive cell line towards the drug.The three
human head neck tumour cell lines, and the fetal lung
fibroblast were comparatively less sensitive to the drug
than the hepatoma cells while Ehrlich ascites tumour cells
seems to be the most resistant one to the drug among the
cell lines tested. The three human head and neck cell lines
showed a reduction of 50 % of incorporation between 7.5 to
13 MM. Therefore they had similar sensitivity in response
to gossypol treatment in spite of different origins of the
cell lines. The morphology of cells were shown in fig. 3-9
to fig. 3-12. At high dose of gossypol treatment (40 pM)
the drug-treated cells were rounded up C HN-6 was an
exception but the morphology of the cell had changed).
3.3.4 The delayed effects of gossypol on cultured cells
The assay systems of cell number counting and
radioisotope incorporation only reflected the immediate
effect of gossypol on the cells. The delayed effects of the
drug can be studied by allowing a recovery period for the
cells after drug treatment.
The cultured cells after drug treatment were given
fresh and drug - free medium and allowed to grow for a
period of 48 hours. Fig. 3-13a and 3 - 13 b showed that the
percentage of human cell lines recovered were further
decreased in the cell recovery assay. This might indicate
that at high dose of gossypol (> 10pM) cell death
continued to occur after removal of the drug or the growth




Fig. 3-9 The morphological change of rat hepatoma after 24




Fig. 3-10 The morphological change of HN- 6 after 24
















Fig.3-13a percentage of cell survived after gossypol breatment
cell survived after 24 hours drug treatment .
cell survived after 24 hours drug treatment and
then 48 hours recovery if fresh drug-free medium
The amount of cell survived was determined by
measuring the protein content of the adherent cell
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Fig. 3-13 b The percentage of cell survived after gossypol
treatment.
]ce11 survived after 24 hours drug treatment
I ce11 survived after 24 hours drug treatment and
48 hours recovery in fresh drug-free medium.
The amount of cell survived was determined by
measuring the protein content of the adherent
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Fig. 3-14 The recovery of cell lines after 24 hours
gossypol treatment and then 48 hours in
fresh and drug-free medium. The recovery
was expressed as the percentage of protein
content of drug- treated cell to that of
the control. The values are presented as
mean± S.E.M. for triplicate results.
Table 3-1. Effect of gossypol on different cell lines
in vitro.






















1 The gossypol concentration reduced the percentage of thymidine
incorporation 50% that of the control.
2
THe gossypol concentration reduced the percentage of cell
recovery 50% that of the control.
N.D.= not done
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3-14 demonstrated the cell recovery of five cell lines.
Except rat hepatoma, the results of cell recovery assay
well correlated with the result of incorporation assay.
Both showed similar dose-dependent curve. High recovering
ability o.f rat hepatoma might be due to the presence of
resistant cell population which remained viable during drug
treatment and was able to multiply after removal of the
drug. Effect of gossypol was summarized in Table 3-1.
3.3.5 Effect of gossypol on the glucose uptake of Ehrlich ascite
tumour and rat he atorna
The glucose uptake of Ehrlich ascites tumour cell and
rat hepatoma were measured using a non-metabolized analog
of glucose, 2-deoxy-D-glucose. The kinetic parameters of
the transport were determined by incubating the Ehrlich
ascites tumour cell for 30 seconds in the 3H-2-deoxy-D-
glucose solution while the hepatoma cell was incubated for
5 minutes in the labelled sugar solution.
3.3.5a Effect of gossypol on the kinetic parameters of Ehrlich
ascites tumour cell
Fig. 3-15 showed the double reciprocal plot of the
glucose uptake in Ehrlich ascites tumour cells under
gossypol treatment. At low gossypol concentration, the
glucose uptake of the cell was not significantly affected.
The tumour cell without drug treatment had Km value of 0.55
mM and a Vmax value of 10.4 n mole /106 cell/ min. This
value was compatible to that obtained by Kaminska (1979).
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Fig. 3-15 The glucose uptake of Ehrlich ascites tumour cells
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The probable error of Km and Vmax values 6% and the values
were determined by linear regression. r values of the double






















Fig. 3-16 The D- glucose sensitive cytochalasin B binding




treatment was close to the control values. However, the
cell after 5 juM drug treatment showed a similar Vmax value
but an altered Km value. The altered Km value implied a
change in the binding affinity of the transporter to the
substrate. This might be due to a change in physiological
state of the cells after gossypol treatment though the
cytotoxicity of 5 juM gossypol indicated from the
incorporation assay was not so significant. Cytochalasin B
binding assay also showed the absence of change in D-
glucose sensitive cytochalasin B binding site in the
presence or absence of gossypol (10 uM). The cytochalasin B
binding assay was showed in fig. 3-16. The binding site
(Bo) and the dissociation constant (Kd) of Ehrlich ascites
tumour were 70.9 p mole 10 cell and 6.7 x 10 M in the
absence of gossypol. In the presence of gossypol( 5 and 10
pM), the Bo values were 61.1 and 69.4 p mole 10 7 cell
while the respective Kd values were 5 X10 7 M. Therefore
the binding site and the dissociation constant differed
slightly. Thus, the glucose uptake of Ehrlich ascites
tumour cell was not altered after low concentration of
gossypol treatment. Whether the drug can alter glucose
transport at high doses requires further experimentation.
3. 3. 5b Effect of gossypol on glucose uptake of rat hepatoma cgJLj
Fig. 3-17 showed the double reciprocal plots of rat
hepatoma's glucose uptake with or without gossypol
treatment. The cell line without gossypol treatment had a
Km value of 0.45 mM and a Vmax value of 2.7 n mole10 cell
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The probable errors of Km and Vmax values 9 and the values
were determined by linear regression. The r values of the
double reciprocal plots were 0.99.
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Km values of 0.68 to 0.75 mM and a Vmax value of 2.73 and
1.57 n mole/ 106 cell/ min. Both Km and Vmax were
changed in hepatoma after gossypol treatment. AT 5 }iM and
10 JIM gossypol concentrations, the percentage of cell
survived was above 80% but the thymidine incorporation of
the cell decreased mark l y( 40% and 15%) and the
uridine and leucine incorporation were also decreased C 80
% at 5 )uM and 40% at 10 uM). Therefore, a reduction of
Vmax value may be due to the reduction of protein
synthesis. The change of Km value may, imply the
interaction of the drug to the transporter. The mechanism
of the interaction between the drug and the transporter
requires further investigation.
3.4 Conclusion
1) Gossypol exerted cytotoxic effect to all the cell lines
studied here. The degree of cytotoxicity varied from one
cell type to the other. The clinical application of
gossypol was possible as the cell recovery assay
demonstrated a differential,.cytotoxic effect of gossypol on
fetal lung' fibroblast and human head neck cancer cell
lines.( 90% of the fibroblast cell survived while only 60
to 40% of the human head neck tumour cell lines survived
at 10 uM, fig. 3-14.).
2) Ehrlich ascites tumour cell was the most resistant one
while hepatoma was the most sensitive one to the drug.
3) At 5 PM and 10 )uM concentrations of gossypol, glucose
transport was affected in rat hepatoma (H-35) but not in
67
Ehrlich ascites tumour cell. The alteration of the
glucose transport in hepatoma cell 1 ine a fight be due to a
reduction of protein synthesis.
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Chapter 4
4. Effect of methotrexate on human head neck cancer cell lines
4.1.1 Methotrexate (MTX) as an anti-metabolite drug
Since Farber and his co-i nvestigators (Farber et al.,
1948) had demonstrated that aminopterin was effective in
producing remissions in acute leukemia, there has been a
sustained interest in testing folate antagonists as anti¬
cancer drugs. In studies with mice bearing the L1210
leukemia, amethopterin (4-amino-1O-N-methy1pteroy1glutamic
acid) and its derviatives, methotrexate (MTX) was also
found to be effective. In fact, MTX has largely replaced
aminopterin in the clinical treatment of cancer. MTX has
been shown to be good to excellent tumour response in
patients with choriocarcinoma( Hertz, et al., 1961),
lymphocytic leukemia,( Holland Glidewell, et al., 1972,
Wang et al., 1976), carcinoma of the breast( Carter et
al., 1972), epidermoid cancer of the head and neck(
Capizzi et al., 1970; Levitt et al., 1971) and
osteosarcoma( Mondah et al., 1981).
Recently, in vitro studies of murine L1210 leukemia
showed synergistic tumour cell killing when methotrexate
(MTX) was used preceding 5- flurouracil( Cadman et al.,
1979; Cadman et al., 1981). Clinical trial of this
sequential MTX 5- flurouracil treatment showed enhanced
toxicity to cancer cells and provided significant long
lasting palliation in patients with recurrent squamous head
and neck cancer (Pitman, et al., 1983).
4.1.2 Chemistry
Methotrexate (MTX) has a molecular weight of 454.46.
The free acids form yellow or yellowish orange
microcrystals, and are practically insoluble in most
organic solvents and sparingly soluble in water. The
disodium salts are extremely water soluble. It decomposes
without melting at about 200°C. In 0.I N sodium hydroxide
solution, MTX gives three absorption maxima( A. max) at 257



















Methotrexate: R— CH3, R'= H
Dichloromethotrexate: R— CH3; R'= CI
Fig. 4- 1 Structure of methotrexate
4.1.3 Blological activity
MTX is transported into cells by a carrier
mediated process. It shares with N-5-formyltetrahydrofolate
and N-5-methyl tetrahydrofolate a common transport system
while folic acid enters the cell through another route.
Different from the other clincially used antimetabolite,
MTX does not require metabolic conversion to active
structure. The drug is classified as phase specific anti¬
cancer drug cytokinetical1y.Thus, MTX kills only those
cells which are in a sensitive phase of the cell cycle.
When MTX enters the cell, it acts as a potent
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DHFR: dihydrofo1 ate reductase
MTX: methotrexate
rHMP-:FHrldyNt- N'°- methylene tetrahydrofolate
showed the site of action of MTX. One mole of enzyme will
bind almost one mole of drug with Ki value of 1011 M
However, in the intact cell the pH is higher, and the
blockade of the enzyme results in elevated level of
dihydrofolate, thus decreasing the binding of enzyme and
inhibitor. Therefore MTX must be in molar excess to the
target enzyme, in order to shut off tetrahydrofolate
synthesis. As a result, DNA synthesis is inhibited due to
deprivation of reduced folate coenzymes for replication. It
is apparent that MTX treatment will also lead to an
impaired regeneration of N5,N10 methenyl- tetrahydrofolate
and N10-formy1-tetrahydrofo1 ate so that purine nucleotide
synthesis may be halted. The drug also inhibits thymidylate
— 5
synthetase but the affinity is low (Ki approximate 10 M).
In addition, protein synthesis is inhibited because
insufficient amount of tetrahydrofo1 ate coenzyme will
affect serine and methionine biosynthesis. C Holland and
Frei et al., 1982)
Recently, many studies on MTX have focused on the
mechanisms of drug resistance of tumour cells. (Alam et
al., 1983; Frai et al., 1984; Schimka et al., 1984) and
the relationship between MTX polyglutamate formation and
the cytotoxicity and sensitivity on tumour cells( Jolivet,
et al., 1985).
In 1979, the studies in Ehrlich ascites tumour cell
demonstrated that MTX also affected energy metabolism in
tumour cells. Anaerobic glycolysis was inhibited in
Ehrlich ascites tumour cell. Moreover, the decrease of
2- deoxy- D- glucose uptake was due to a change of Vmax
but not its Km values in the presence of MTX (Kaminska et
al., 1979). This phenomenon was also found in vivo. The
number of glucose- reversible binding sites of
cytochalasin B was decreased in the presence of MTX( Chan,
et al., 1983).
4.2 Aim of study
The glucose transport system of tumour cells has
been a subject of intensive investigation. The ultimate
goal of such efforts is to clarify how glucose is ultilized
by tumour cells. In fact, enhanced glucose transport has
been related to the state of transformation of cell lines
(Lang Weber et al. 1978; Eigenbrodt Glossmann et al,
1980; Koren et al. 1980). Recently, Kaminska and Chan
showed that MTX can affect the glucose ultilization in
cultured cell line. However, the studies were carried out
in Ehrlich ascites tumour which is an animal tumour. It
will be worthwhile to examine whether this drug
efffect is also seen in human cancer cells.
Since it is not possible to do i_n vivo
experiment in human being, the alternation is to use
established human cell lines for j_n v]_tro study. The cell
lines that we chosen are human head and neck squamous
carcinoma cell lines because carcinoma accounts for 90 of
human tumours. Moreover, clinical trials of MTX on human
head neck tumour patients showed 30 to 50 drug response
(Bertino et al. 1975).
In this part of thesis, the cytotoxicity of
methotrexate on the human head and neck tumour cell lines
was measured. And then, the 2-deoxy-D-glucose transport of
some of the human head neck tumour cell lines was
examined to see whether the drug can affect the glucose
transport in human cancer cell lines or not.
4.3 Materials and methods
4.3.1 Pulse labelling of radioactive nucleotides and H-leucine.
4.3.2 Cell recovery assay
4.3.1 and 4.3.2 have been mentioned in Chapter Ill.sectior
3 9.
4.3.3 Glucose uptake of human head and neck cell lines
The assay method was modified from the procedure
rpnorted bv Amina Klin (1982).
cells were plated in 1 cm diameter 24-wel]
plate (Limbo) and allowed to grow for 16- 24 hours before
incubation with drugs. The cells were then incubated with
MTX for 24 hours before glucose uptake determination. All
measurements were carried out at 37 °C. The medium in the
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wells was aspirated and the cells were washed three times
with phosphate buffered saline. 0.4 ml of different
concentrations of 2- deoxy- D- glucose( 3 pCi V p mole
was added to each well and incubated for 1 minute. After
the incubation, the cells were rapidly washed with phosphate
buffered saline supplemented with 20 mM of
2- deoxy- D- glucose (grade II). Then the cells were
solubilized into 0.65 ml 0.4 M NaOH and digested overnight
at room temperature. 0.5 ml of aliquot _was taken for liquid
scintillation counting in 3 ml scintillation fluid. The
radioactivity was counted in a Beckman LS- 7000 liquid
scintillation counter. Carrier- dependent transport was
calculated by the difference of the uptake in the presence
of 10 }iM cytochalasin B. The carrier kinetic parameters,
Vmax and Km, representing respectively the maximal uptake
and apparent half- saturation constant for the specific
transport process, were determined by double- reciprocal
plots.
4.4 Results and discussion
4.4.1 Cytotoxic effect of Methotrexate (MTX) on Human Cell Lines
The cytotoxic effects of methotrexate on human cell
lines were determined according to the methods mentioned in
chapter III. The cell lines. employed in the assays included
two fibroblast cell lines (fetal skin fibroblast and fetal
lung fibroblast) and five head and neck squamous carcinoma
HN- 6, HN- 6Lr, HN- 6 Rr, HN- 6 n1, and HN- 6 n2.
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Details of their origins were mentioned in the appendix I
Fig. 4- 3 showed the percentage of surviving cell after
24 hours MTX treatment. The drug was effective at 10-6 M
MTX concentration. Most of the cell lines showed a
decrease in ce 1.1 number. Only 70- 85% of the cell
survived after the drug treatment.
4.4.2 Effect of MTX on the radioactive nucleGsides and leucine
incorporation
Fig. 4- 4, to fig. 4 -10 showed the effects of
me tho tre rate on the thymidine, ur idi ne and leucine
incorporation. The incorporation was expressed as the
percentage of radioactive labels incorporated as compared
with the control. All the cell lines examined responsed
with an increase of thymidine incorporation as the doses of
the drug increased. The extent of increment of the
incorporation varied from cell to cell. Even among the five
human tumour cell 1ines, the percentage of increase of
thymidine incorporation varied from 1.4 fold C HN- 6n2)
to 3.8 fold( HN- 6). Moreover, the two normal cell 1ine
fetal lung fibroblast and fetal skin fibroblast also
showed a quite distinct response towards the drug. The
fetal skin fibroblast only showed a 1.4 fold increase of
the thymidine incorporation. However, the fetal lung
fibroblast re sponse d with a 3 fold increase in thymidine
incorporation. So, the degree of increase of thymidine
incorporation was cell type specific. The increase in
thymidine incorporation of the cell might reflect an

































LOG MTX CONCENTRATION CM)
Fig 4.3 The percentage of ceil survival after 24 hours MTX
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i n 4
LOG MTX CONCENTRATION (M)
ia 4-4 The percentage of thymidine leucine and uridine
9' incorporation of fetal skin fibroblast after 24
hnnrs MTX treatment.
: thymidine
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Fiq 4-5 The percentage of thymidine, uridine and leucine
































CONTROL 108 107 106 10 5 10 4
LOG MTX CONCENTRATION CM)
Fig. 4-6 The percentage of thymidine, uridine and leucine

































CONTROL 10-8 10 7 10~6 10 5 10-4
LOG MTX CONCENTRATION CM)
Fig. 4-7 The percentage of thymidine, uridine and leucine
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Fiq 4-8 The percentage of thymidine, uridine and leucin
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Fig. 4-9 The percentage of thymidine, uridine and leucin









Fig. 4-10 The percentage of thymidine, uridine and leucir
IncorDoration of HN- 6n2 after 24 hours MTX
treatment
O: thym id in
0: uridine
□: leucine
The values are presented as mean± S.E.M. for
triplicate results
CONTROL
CMordoh et al., 1981) as the de novo synthesis of
thymidine monophosphate was blocked by methotrexate. DNA
synthesis appeared to be more susceptible to MTX treatment
than RNA and protein synthesis.
4.4.3 Cell recovery after MTX treatment
Even though the drug was removed from the medium of
the cell lines, the drug effect might persist. Therefore,
the degree of recovery of cell lines after 24 hours drug
treatment was measured by giving fresh, drug- free medium
to the MTX- treated cell lines. Then they were allowed to
grow for further 48 hours in this medium. Giant cells which
were observed in the culture of four tumour cell lines
treated with 10 M MTX concentration, were shown in
fig. 4-11 to fig. 4-14. These cells reflected a
termination of cell division at the Go phase. The cells
were enlarged and eventually died. The recovery of each
cell lines was expressed as the percentage of the total
cell protein content of drug- treated cell divided by the
control one. Fig. 4-15 showed the cell recovery of the
cell lines at different dose of MTX. The cell recovery
assay was in agreement with the result of thymidine
incorporation- the dose of MTX required to reduce cell
number by 50% was around 10 6M. HN- 6 was slightly more
resistant to the drug among the four human head and neck
tumour cell lines. This might be partially due to an highly
activated salvage pathway of thymidine. In addition, MTX is




Fig. 4- 11 Morphological change of HN- 6 after 24 hours






Fig. 4- 12 Morphological change of HN- 6Lr after 24 hours





Fig. 4- 13 Morphological change of HN- 6n1 after 24 hours





Fig. 4- 14 Morphological change of HN- 6n2 aster 24 hnours


























: fetal skin fibroblast





CONTROL 10~8 10~7 10 6 10 5 10 4
LOG MTX CONCENTRATION CM)
Fig. 4-15 The recovery of cell 1 ine after 24 hours MTX
treatment and then 48 hours an fresh, drug- free
medium. The recovery was expressed as percentage
of protein content of drug- treated cell over
the control.
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phase will determine the sensitivity of the cell line
towards the drug especially for short term of drug
incubation. Thus for two slower growing fetal fibroblast
cell lines, the drug resistance might be contributed by the
second fartnr
4.4.4 Effect of MTX on l ucose uptake of human head and neck
tumour cell line
Before measuring the drug effect on glucose uptake,
the time course of three cell lines were measured
and the data was shown in fig. 4- 16 to fig. 4- 18.
They were HN- 62 HN- 6 Lr and HN- 6 n i. They
represented three different cancerous stage: the primary,
the local reccurrence and the lymph node metastasis. Since
the uptake rate among all the cell lines remained linear in
the first two minute duration, the Km and Vmax values of
the cell lines were determined by incubating the cells in
H- 2- deoxy- D- glucose for one minute. All the cell
lines showed a cytochalasin B sensitive saturable 2-deoxy-
D-gl ucose uptake fig. 4 -19, f ig. 4-20 and f ig. 4- 21. For
drug effect on the transporter, the cells were pre-
incubrated in 10-6M MTX concentration for 24 hours before
performing the glucose uptake assay. Table (4- 1) showed
the change of Km and Vmax values of each cell lines in the
presence of the drug. Both Km and Vmax were reduced in the
-6
presence of 10 M MTX concentration. HcDwe ver Kam i nska and
Chan reported a decrease of Vmax values but no change of Km
values in Ehrlich ascites tumour cells. (Kaminskas E. et





































Fig. 4-16 The time course of 2-deoiy-D-gl ucose uptake in HN- 6
7 X 104 cellwell was seeded to each well and
2-deoxy-D-g1ucose uptake was performed according

































The time course of 2-deoxy-D-glucose uptake in HN- 61
7 X 104 cellwell was seeded to each well and
2-deoxy-D-glucose uptake was performed according




































Fig. 4-18 The time course of 2-deoxy-D-glucose uptake in HN-(
7 X 104 cell/well was seeded to each well and
2-deoxy-D-glucose uptake was performed according

































2 4 6 8
2-DEOXY-D-GLUCOSE CONC. (mM)
Fig. 4-19 The 2-deoxy-D-glucose uptake of HN- 6 ,7 X 104 cell/wel
was seeded to each well and performed according to
material&method
: ;3H- 2- deoxy- D- glucose uptake
: 3H- 2- deoxy- D- glucose uptake in the
































2 4 6 8 1C
2-DEOXY-D-GLUCOSE CONC. CmM)
Fig. 4-20 The 2-deoxy-D-glucose uptake of HN- 6Lr 7 X 104
cellwell was seeded to each well and performed accordi
to matpriAl mpfhnH••• W Ml Vf V fc m V v«•O
- 2- deoxy- D- glucose uptake
: H- 2- deoxy- D- glucose uptake in the




































5 d f a
2-DEOXY-D-GLUCOSE CONC. (mM)
Fig. 4-21 The 2-deoxy-D-g1ucose uptake of HN- 6ni,7 X 104
cellwell was seeded to each well and performed accordir
M -V iA I 1 C. frt D t H d M
3 h- 2- deoxy- D- glucose uptake
. 3 |_j- 2- deoxy- D- glucose uptake in the
presence of cytochalasin B
Table 4- 1




















Table 4- 1: The Km and Vmax of HN- 6, HN- 6Lr and
HN- 6nl after 10~6 M MTX treatment. The




Vmax values among the three human cell lines might be
due to several reasons. The drug could decrease
adenosine- 5- triphosphate pools In Ehrlich ascites
tumour cells( Kaminska E. et al., 1979). Moreover, the
hexokinase activity was reported to decrease after 24 hours
drug incubation C Kaminaka E. et al., 1979). The decrease
in Km value was not clearly understood at the present
stage and required further investigation.
4.5 Conclus ion
In v i tr o cell culture s t ud i e s de monstrated a decrease of
cell number after MTX treatment. Delay effect of the drug
on survival of the cells was more clearly seen when the
drug-treated cell was allowed to recover after a period of
—6
48 hours. 10 M of the drug was required in most cases
to reduce the cell number to half. The drug, somehow,
activated the salvage pathway of pyrimidine synthesis. This
might partially contribute to the resistance of the cell
lines towards the drug. Cells which were sensitive to the
drug were terminated at Go phase and eventually killed. The
drug not only blocked the DNA synthesis of the cell
line but it also inhibited the 2- deoxy- D
glucose uptake rate of three human cancer cell lines. Both
the Km and Vmax values of the glucose uptake were affected.
The underlying meaning of such kind of changes required




5 •1 CYtgtQlC effect of qpssvpol on tumour eel]
Intraperitoneal administration of gossypol to Ehrlich
ascites tumour- bearing mice shows a prolonged life span at
high doses( fig 2.4 and fig 2.5). 50% survival is observed
in tumour- bearing mice treated with 100 300 jag of
gossypol on 15th day( Fig 2.5) while only 10% survival
rate is found in the control group on the same day. This is
in agreement with the previous work by Tso( 1984) that
gossypol can prolong the life span of Ehrlich ascites tumour
bearing-mice.
In y i tro cell culture study of the drug has further
clarified the cytotoxic effect on both normal and malignant
cell lines. However, the recovery assay of different cell
lines reflects different sensitivites of ze11s towards the
drug. The differential recovery of the ftuman tumour cells
and normal fetal fibroblast cell may imply a possible
clinical application of the drug.
5.2 Action mechanism of gossypol on tumour celU
Experimental data indicated that a number of biochemical
changes occurred after gossypol treatment.
The total lactate dehydrogenase activity was reduced
after drug treatment. This was in agreement with the findings
in the other cell types. Gossypol was fxund to reduce the
level of LDH X and the LDH 1 in human sperm( Xue et al. 1982
). The other finding also implied that the lactate
dehydrogenase might be the target enzyme of gossypol in colon
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carcinoma and melanoma( Tuszynski et al. 1984). Inhibition
of lactate dehydrogenase may be significant in tumour cells
which are known to have high rate of aerobic glycolysis and
lactate production( Warburg et al. 1956).-
The rate of oxygen consumption was also found to be
reduced after drug treatment( fig. 2-7, Chapter 2). The
rate of oxygen consumption would reflect the state. of
aerobic respiration in the cells. A decreased in oxygen
consumption implied that the respiratory chain might. be
inhibited. The inhibition of the respiratory chain might be
due to the interaction of the drug with the electron
carriers. The other studies had supported that the
respiratory chain in mitochondria is affected. Floridi et al
(1984) had observed a deformation of isolated mitochondria of
Ehrlich ascites tumour after direct addition of high dose of
gossypol.
Since a differential drug response was found among
different cell 1ines (Table 3-1), the effect of gossypol
might be specific to different types of cells. This specificity
may be due to difference in the rates of uptake of the drug
or difference in the tolerance to the drug. The second reason
seemed to be more probable as a differential inhibition of
mitochondrial respiratory chain was observed in isolated
mitochondria of testis and liver( Inchull et al. 1984).
5.3 Prtnial of gossypol as an anti- cancer drug
Use of the drug as male antifertility in human being
does not reveal a significant side effect to, normal tissues
Moreover, the drug does not appear to be mutagenic
and organs.
to the results of the Ames test and the sperm head
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abnormality assay in mice. At low doses of gossypol, there is
no aberration of chromosome in human peripheral lymphocyte
CO. 2- 20 mg Kg day dose) nor increase in sister
chromatid exchange in spermatogonial cells in nice (less
than 8 mg Kg). Details of recent studies on the drug is
reviewed by Qian Wang( 1984) The studies on
spermatogonial cells and Ehrlich ascites cell( Xue et al.
1982; Floridi et al 1984 )further indicate that energy
metabolism rather than DNA synthesis was inhibited by the
drug. Therefore, gossypol will have an advantage over
conventional anti- cancer drug since 51 will not affect the
proliferation of normal tissues such as bone marrow. However,
the clinical application of the drug remains to be a problem
because of hypokalemic paralysis occurs in certain cases. And
also, we observed accumulation of gossypol at the gastro¬
intestinal region of drug- treated mice. This may have toxic
effects to the organs. Furthermore, the sensitivity of solid
tumour to the drug remains unknown.
5. 4 Comparison of t.hf drng pffect. of nosSYDnl with methotrexate
Both drugs show cytotoxic effects to the cell lines
tested at jjM level. The patterns of incorporation of the H
- precursors of DNA, RNA and protein synthesis in the cell
lines indicate that gossypol and MTX have different action
mechanisms. Most of the cells response with an elevation
of the salvage pathway of thymidine after MTX treatment.
Cells which can obtain the necessary thymidine from the
culture medium, are able to overcome the blockade of
dihydrofolate reductase by MTX and survived. However, the MTX
sensitive cells will have a permanent change after the drug
treatment which reflected by the formation of giant cells(
fig. 4-11 to fig. 4-14). On the other hand, cells response to
gossypol treatment with a reduction of the thymidine, uridine
and leucine IncorporatIon. The decrease of Incorporation may
be largely due to a reduction of cell number rather than a
specific effect on the synthesis of DNA, RNA and protein.
Both the recovery assays of the two drugs have demonstrated
that there is differential drug effects on the tumour cells
and on the non-transformed cells(fetal lung fibroblast).
Apart from the cytotoxicity, both drugs showed an inhibition
of glucose transport in certain cell lines( the glucose
transport of Ehrlich ascites tumour cellsls not affected as
the dose of gossypol used is below the cytotoxic level of the
drug on the cells. Probably at high dose of gossypol,
inhibition effect can be observed.) The drugs inhibit both
the Km and Vmax values. The change in Vraax values may be due
to a decrease of protein synthesis in the gossypol treated
cells. The alteration of Km value in gossypol treated cell is
not clear and it may be due to an interaction of the drug to
the transporter or via a change in energy state of the cell s.
The underlying mechanism of the change in Km values in
gossypo1 -treated ce1 Isrequired further experimentation. The
inhibitory effect of MTX on the glucose uptake of the head
and neck tumour seems to be due to another reasons. MTX
affected Km and Vmax values of the human cell lines. Since
the incorporation of labelled leucine to the tumour cellswas
not significantly altered, the decrease in Vmax value was not
due to reduction of protein synthesis. Probably, a decrease
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of Vmax value was due to decrease of hexose kinase activity
and a lower level of cellular ATP content. A reduction of
hexose kinase and decrease of cellular ATP content was
reported in Ehrl ich ascites tumour cells after MTX treatment(
Kaminska et al. 1979). Moreover, cells after MTX treatment,
may response with an elevation of phosphoribosylpyrophosphate
(PRPP) (Cadman et al. 1981 )and high concentration of PRPP
has been implied to have inhibitory effect to glucose
transport in culture chicken- embryo fibroblast (Gay and
Amos, 1983). The change in Km values in MTX treated-cells
remains unclear and requires further investigation g
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5.5 Scope of future study
5.5.1 choice of mode 1
Apart from using Ln cell culture assays of the
drug on the human tumour cell lines, an alternative can be
used: inject the tumour into nude mice and observe the drug
effect directly in an in, xj-yLo system. The xenografted
tumour very often retains the characteristic features of
the original tumours (Helson, et al. 1980). Most of the
human cancer cell lines, HN-6, HN-6Rr, HN-'6Lr and HN-6n1
are able to form xenograft when they are transplanted into
immune deficient mice (Tsao et al. 1985). They can be
used in further study.
5.5.2 Modification of drug screen assay
Clonogenic assay can be used in studying the effect of
drugs on cells since it is reported that the result of the
assay correlates better to the clinical observation of drug
effect ( Roper and Drewirko, 1976). In our present series
of cell lines tested only hepatoma readily forms clone in
soft agar while the other cell lines may require more
complicated conditions for clone formation. In order to
overcome the restriction in the use of cell line, the assay
can be modified. Instead of counting the clones formed in
soft agar, we can dilute the concentration of drug-treated
cells and count their plating efficiency on culture dish.
Both clonogenic assay and plating efficiency assay have the
advantage that the ability of the cells to proliferate is
measured rather than other indirect parameters such as
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thym i dine incorporation and protein synthesis. However,
both assays require two weeks for the formation of clones
but the results of radioactive nucleoside incorporation and
protein synthesis can be obtained within a few days.
Therefore thymidine incorporation and protein synthesis.
were used as the screen assays in this study because of
their simplicity and less time-consuming than the clonogenic
assay.
5.5.3 Biochemical changes accomplished with gossypol treatment
Alteration of energy metabolism is implied in drug
treated cell. Here only a limited number of properties of
the cell are studied. A number of experiments are suggested
in the followings:
1) The decrease in the total activity of lactate dehydrogenase
implied a reduction of the enzyme level. It will be
worthwhile to see which isozymes are affected after the
drug treatment. And this can be proved by determining the
electrophore t i c pattern of the LDH isozyme of the cells
before or after gossypol treatment.
2) Gossypol was found to affect membrane Na+/ K+ ATPase and
membrane proteolytis activity. This implies a possible
interaction of the drug to plasma membrane. A preliminary
study of the drug effect on the cell membrane can be done
by surface labelling of the membrane proteins by 125 I
or NaB3H4 C Hubbard and Cohn, 1975 Baumann and Doyle,
1978) and then separates the labelled proteins by gel
electrophoresis. NaB 3 H4 w111 specifically label the surface
glycoprotein (Baumann and Doyle, 1978).
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3) Since energy metabolism is implied to be affected, the
level of the ATP of the cell may also be altered. The level
of ATP can be measured by a kit of Sigma.
4) The site of inhibition of gossypol on respiratory chain
remains unclear though dehydrogenases are implied as the
target sites (Floridi and Lehninger, 1983)
There will be a need of studying the kinetics of
enzymes involved in the oxidative phosphorylation in the
presence of gossypol.
5.5.4 Biochemical changes associated with methotrexat treatment
The incorporation assays of the human tumour cell
lines showed an elevation of thymidine incorporation. This
is different from that observed in Ehrlich ascites tumour
cells (Kaminska et al. 1979) which responsed with a
decrease of thymidine incorporation. Thus the mechanism of
reduction of the glucose transport in human. tumour cell
lines, may be different from that of Ehrlich ascites tumour
cell. The decrease of the glucose transport in Ehrlich
ascites tumour cell may be due to decrease of protein
synthesis and depletion of ATP (Kaminska et al. 1979).
Since phosphor i bos yl pyrophospha to (PRPP) has been implied
to inhibit the glucose transport in methotrexate treated
cells, the level of PRPP in the human tumour cells may be
determined. This can verify the role of PRPP in glucose
transport and the mechanism behind the inhibition of
glucose uptake of MTX-treated human tumour cells C It has
been mentioned in the discussion section 5.4) In addition,
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the differences in the degree of thym id ine incorporation
among the cell lines studied may implied different uptake
rates of exogenous nucleosides. As the primary tumour cells
seem to be more resistant to methotrexate treatment, one of
the possible explanation is that the cells can obtain
sufficient thymidine and overcome the blockade of
dihydrofolate reductase by methotrexate. Therefore it is
necessary to clarify whether the primary tumour cells have




I Origin of cell lines
I.1 Ehrlich ascites tumour
Ehrlich ascites tumour was derived from a spontaneous
murine mammary adenocarcinoma C Ehrlich and Apolant, 1905).
It was converted into ascites form by Lowerthal and Jahn C
1932) and carried in outbred mice by serial intraper i toneal
passage. The subline we used is Ny Klein Strain which was
established by Klein and Klein C 1956). Ehrlich ascites
.tumour cells can be grown in mice or in suspension form of
cell culture. The tumour can be transplanted from mice to
ran 1 t nre an vine versa.
I.2 gat heDatgma (H- 35)
Rat hepatoma was first obtained by inducing the A X C
strain rats with N- 2- flurenyldfacetamide.. The tumour was
transplanted subcutaneously to A X C strain rats C Reuber et.
al 1961). Later, hepatoma C H- 35) was adapted to in- vitro
culture by Pitot. It was found that i- vitro cultured
hepatoma showed a de-f icien-cy in certain enzymes as compared
with liver and hepatoma (H- 35) is vivo i.e. tryptophan
PYrrolase, glucose- 6- phosphate de hydroge nase and pro l i ne
oxidase. However, the hepatic marker enzymes, histidase,
ornithine transaminase, tyrosine transaminase, thymine
reductase, and glucokinase were present at measurable levels
in the cultured cells. (Pitot, 1964)
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I.3 Human head and neck tumour cell lines
The five tumour cell lines were obtained from the
Ludwig Institute for Cancer Research (London). They are
derived from the primary, local recurrent and metastastic
tumours of the same patient. The cell lines shared many
morphological and biochemical characteristics. The locations
and histological gradings of the tumours were mentioned in
Table I.I.
Table I. 1 The locations and histological grading of human
head and neck tumour cell lines.(Easty et al 1981)
locationTumour cell surgical pathology
line













The growth curve of the cell lines were d. snuwed in
figI-1. HN-6Rr and HN-6Lr had the shortest doubling times
while HN-6n1 and HN-6n2 had the longest doubling time. The
primary tumour, HN-6, showed growth inhibition at confluency.
However, HN-6Lr, HN-6n1 and HN-6n2 did not show such kind
of growth inhibition. In fact, piling was observed in HN-6Lr
















Fig. 11— 1 The growth curves of the human head and neck tumour
ce11 1ines.












be found in ,Chapter 4 (fig. 4.11 to 4.14) and in appendix II
( fig. II-1).
Biochemical assays on the cell lines had shown no
carc inoembryon is antigen but all released very similar
quantitites of immumoreactive B- hcG into the culture medium.
( Easty et al 1981) The surface membrane of three of the
cell lines were studied by cell surface labelling. This is
mentioned in Appendix II.
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II. Electrophoretic characterization of cell surface membrane
proteins of human head and neck squamous carcinoma
II.1 Introduction
Extensive studies have showned alterations of plasma
membrane i n tumour cells. They Include change i n cell
agglutinabil ity by lectins and altered composition of
gl ycoprote i ns and glycolipids ( Ruddon et al. 1981).
Change of lectin agglutinability was first
demonstrated by Aub.(1965) He found that an extract of wheat
germ agglutinated several transformed cell lines but not
their normal counterparts. Nicolson (1976) further pointed
out a positive correlation between the degree of
agglutinability and malignancy. The increase in lectin
agglut inabl i l ty of transformed cell is due to a change of
membrane fluidity of the plasma membrane of malignant
cells. (Nicolson et al 1976 Phillips et al 1974).
A number of changes in the composition of membrane
gl j ycoprote ins and If glycol ipids have been noted in
transformed cells. Sialosyl-oligosaccharides containing
gl ycopro to i ns were observed in viral- transformed cells.
(Sakiyama and Burge, 1972 Warren et al 1972) And
altered high molecular weight glycoproteins also appeared
in a wide range of tumorigenic cells (Bramwell Harris,
1978 Kayama et al 1979). Moreover, incomplete
processing or synthesis of carbohydrate portion of membrane
glycoprote ins and glycolipids (Hakonori et al 1975
Brady Fishman 1974) was implied as the cause of this
alterations. In addition, change of glycosyltransferase
level might also take an important role in the change of
116
membrane glycoproteins. (Warren, et al 1972; Bosmann and
Hall, 1974)
II.2 Aim of study
The purpose of this study is to analyse the possible
membrane alteration among primary, local recurrent and
metastatic stages of squamous carcinoma. Studies of
certain primary tumour and its metastases had showed
different surface protein patterns between them.( Chan, et
al. 1984) Here, the primary, recurrent and metastatic
tumours are originated from the same cancer patient. Any
change in membrane proteins may reflect the existence of
tumour antigen in the cell line as they are histochem ical l y
compatible. They are morphologically distinct. The primary
tumour shows grow inhibition upon confluency (shown in
appendix I) while the other two cell lines are not. HN-6n1
piles up even at the log phase of the growth curve. In
addition, HN-6Lr and HN-6n1 can form xenografts in nude
mice but not the primary one. (Tsao, et al 1985) Normal
human fetal tongue epithelium and normal human fetal
fibroblast were used as normal counterparts of the tumour
cells.
The membrane was labelled by enzymatic iodination of
cell surface.
11.3 Materials and methods
Enzymatic iodination of human head neck tumour cells
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The enzymatic iodination was performed according to
the method of Hubbard. (Hubbard Cohn et al 1975 Der
Starbridge et al 1981).
The cells were first plated on 60_ mm diameter
culture dishes (Falcon) and allowed to grow to confluency
after 48 hours. Then, the cells were washed three times
with phosphate buffered saline and iodinated with 2 ml of
buffered saline containing 12 units lactoperoxidase(
Calbiochem), 12 units glucose oxidase (Sigma), 50 mM D-
glucose and 0.2 mCi 125I (Amersham). The reaction was
allowed to progress for 10 minutes at room temperature and
was shaken occasionally. The reaction was halted by the
addition of ice- cold phosphate buffered iodide containing
2 mM phenylmethylsulfonyl fluoride and followed by three
washes in the same buffer. The iodinated cells were scraped
by a rubber policeman and washed once with the phosphate
buffered iodide. (the molarity of iodide is equivalent to
that of chloride in phosphate buffered saline) The cells
were dissolved into 200 pl electrophoretic sample buffer
containing 2-mercaptoethanol and then was boiled in water
bath for 2 minutes times. In certain case, the iodinated
cells were precipitated with 10% trichloroacetic acid and
then 100% ice-cold acetone before solubilized in the sample
buffer solution.
Discontinous SDS- polyacrylamide gel electrophoresis
Sodium dodecyl sulphate (SDS) polyacrylamide slab gel
electrophoresis was used to separate different proteins of
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human head neck tumour cell lines.
The buffer system for the resolving and stackng gel
was according to Laemmli.(et al 1970) Stacking and
resolving gels were cast from acrylamide stock solution
containing 30% (w/v) acrylamide and 0.6% (w/v) N,N-
methylene bisacrylamide. Polymerization was initiated by
small amounts of ammonium persulphate in the presence of
the catalyst N, N, N' ,N',- tetramethylenediamine (TEMED).
The resolving gel contained 0.19 M Tris- HC1
(pH8.8), 0.1% SDS, and 7.5% acrylamide. The stacking gel
contained 0.063 M Tris- HCl (pH6.8), 0:1% SDS and 4% (w/v)
acrylamide. Electrophoresis was performed at 25 mA for 3-4
hours. The slab gel was stained by coomassie blue and
dried. Autoradiographs were made on Kodak X- Omat film.
II.4 Rps-ulits and Discussion
The appearance `of human head and neck cell lines
were showed in f ig. II-I. The electrophoretic patterns of
total cell prate-in did not indicate any difference
among the cell lines, fig. 11-2. The autoradiograph
revealed a different protein pattern as compared to the
coomassie blue electropherogram. This showed that not all
the proteins will be labelled by this method and only cell
surface protein will be labelled. The labelled protein
pattern of the three human cell lines are similar. The
different intensity of the band may be due to differences
in radioactivity of the.sample rather than* the actual
quantitative difference o f the protein. There was a band(
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HN- 6 HN- 6Lr
HN- 6n1














(1) total cell protein
(2) labelled cell surface protein
Fig. II- 2 Gel electropherograms and autoradiograph of
three human head and neck cancer cell lines
labelled by LI )absent in the au torad i ograph of the
metastasis (HN-6nl). It is not clear whether the phenomenon
is a characteristic of the metastasis or not.It was found
that the characteristic antigen of metastases will change
to that of the primary tumour if the cell is allowed to
growth in the site of the primary one (Chan et al. 1984).
Since other components of the membrane may also be labelled
by radioactive iodine, the iodinated whole cell instead of
directly solubilized Into the sample buffer, was sedimented
with 10 k trichloroacetic acid and then 100 k acetone
fig. II-3. Th LI protein band was lost but a band (L2) of
205 K was found in the primary ,HN-6, but not in the
metastasis,HN-6nl. The local recurrence, HN-6Lr ,showed a
faint band of the same molecular weight. The disapparance
of band (LI) revealed that the protein may contain lipid
portion which makes the protein solubilized in acetone or
the band is lipid in nature.The absence of band L2 in
fig.II-2 may be due to the overlapping of bands around
205K.
Besides, comparing the membrane protein pattern of
tumour celh1ines of different stages, a comparison is made
between the tumour cell and its normal counterparts. The
cells that can be used for comparison are the primary
cultures of normal fetal tongue epithelium and normal
fetal fibroblast which was kindly prepared by Dr. G Tsao.
The morphology of the tumour cell and the normal cell are
shown in fig. 11— 4. The e1ectropherogram of the tumour cell













(1) total cell protein
(2) labelled cell surface protein
* samples precipitated with 10% trichloroacetic acid s
10% acetone.
Fig. II- 3 Gel electropherograms and autoradiograph of
three human head and neck cancer cell lines,
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fetal tongue epitheliumHN- 6
fetal fibroblast
Fig. II- 4 Morphology of HN- 6, normal fetal tongue











A= normal fetal tongue epithelium
B= HN- 6
C= normal fetal fibroblast
(1) total cell protein
(2) labelled cell surface protein
Fig. II- 5 Gel electropherograms and autoradiograph of
primary head and neck cancer cell and the
primary culture of normal fetal tongue
epithelium and normal fetal fibroblast.
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The three kind of cells showed distinct total cell protein
patterns. The majority of the protein bands of fetal
epithelium concentrated between 29K and 66K but there was a
single band localized around 1 16K. The intensity of the
band is very high. This may indicate the abundancy of the
protein. Both normal fetal fibroblast and the tongue
squamous carcinoma. did not show the similar protein
pattern. This may be due to two different reasons: the
protein pattern of the normal fetal epithelium is tissue
specific and the pattern is not comparable to the tumour
cell may indicate an alteration of membrane protein during
carcinogenesis. Or, the difference in protein pattern is a
result of difference in nutrition and environmemt. The
tumour cell and the fetal fibroblast was maintained in 10%
fetal calf serum and the same culture medium. However, the
medium of the primary culture of fetal epithelium was
enriched with epidermal growth factor and etc. In fact, the
second reason is more probable because the membrane protein
pattern revealed by the autoradiography showed a similarity
between the fetal-fibroblast cell and the tumour cell. This
gives us a hint that the identical protein bands between
the fetal fibroblast and the tumour cell may he a result of
adaptation to in vitro culture. It should be. noted that the
fetal fibroblast has slow growth rate, show contact
inhibition and stop proliferation after several
passages.The difference in protein pattern between the
fibroblast and the tumour cell may imply the existence of
tumour antigen. Meanwhile, the labelled protein pattern of
normal fetal epithelium cell may represent the case of
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normal cell whose proliferation is still under
environmental control.e.g. epidermal growth factor.Another
separate experiment confirmed that fetal epithelial cell of
the same histological origin will show a similar 'pattern of
surface membrane protein. The data was shown in fig. 11-6.
The absence of protein pattern around 116K may be due to
individual difference.
- 205 K-









A= normal fetal tongue epithelium
B= HN- 6
CI) total cell protein
(2) labelled cell surface protein
Fig. II- 6 Gel electropherograms and autoradiograph of
the primary head and neck cancer cell line




Autoradiographs of tumour cell of different cancerous
stages have similar surface membrane protein pattern. One
protein band was absent in the metastasis which may imply
the lost of certain characteristics of the primary tumour.
Whether the antigen will reappear on the metastasis require
further experimentation. The difference between the membrane
protein pattern of the normal fetal tongue epithelial cell
and the tumour cell does not related to the cancerous stage
of the tumour but rather is a result of environmental and
nutritional change. Similarity of the membrane protein
pattern of the fetal fibroblast and the tumour may show a
certain essential requirement of cell to proliferate in
vitro. The membrane protein of fetal epithelium of same
histological origin showed similar membrane protein pattern.
The pattern may be the characteristics of normal epithelium
under environmental control.Details of the nature of the
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